1. Home
  2. CLOV vs NVAX Comparison

CLOV vs NVAX Comparison

Compare CLOV & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clover Health Investments Corp.

CLOV

Clover Health Investments Corp.

HOLD

Current Price

$4.32

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$7.56

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLOV
NVAX
Founded
2014
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
CLOV
NVAX
Price
$4.32
$7.56
Analyst Decision
Buy
Hold
Analyst Count
3
9
Target Price
$2.90
$11.33
AVG Volume (30 Days)
5.3M
3.4M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
38.03
309.76
EPS
0.05
N/A
Revenue
$1,924,308,000.00
$1,123,479,000.00
Revenue This Year
$52.59
N/A
Revenue Next Year
$15.37
N/A
P/E Ratio
$86.40
N/A
Revenue Growth
40.34
64.69
52 Week Low
$1.58
$6.20
52 Week High
$5.59
$11.85

Technical Indicators

Market Signals
Indicator
CLOV
NVAX
Relative Strength Index (RSI) 43.50 33.90
Support Level $1.96 $6.38
Resistance Level $5.18 $10.10
Average True Range (ATR) 0.25 0.35
MACD -0.08 -0.12
Stochastic Oscillator 3.73 8.93

Price Performance

Historical Comparison
CLOV
NVAX

About CLOV Clover Health Investments Corp.

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: